Regarding the low expression level of myostatin, the study showed a two-fold or higher decrease in circulating myostatin in the most atrophic disease, spinal muscular atrophy (SMA), and the most wasting disease, DMD. This evidence concerns the gene MSTN and proximal spinal muscular atrophy.